USANA Health Sciences (NYSE:USNA) Issues Quarterly Earnings Results

Key Points

• USANA reported a quarterly loss of $0.11 per share, missing the $0.11 profit analysts expected by $0.22. Revenue was $205.89 million, below the $217.42 million consensus estimate.
• Shares rose 1.3% to $14.91 during Tuesday trading, despite the earnings and revenue shortfalls.
• Analyst views remain cautious: MarketBeat reported an average rating of “Reduce,” with one Hold rating and one Sell rating.

USANA Health Sciences (NYSE:USNA - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.22), FiscalAI reports. USANA Health Sciences had a negative net margin of 2.43% and a positive return on equity of 3.41%. The company had revenue of $205.89 million for the quarter, compared to analysts' expectations of $217.42 million.

USANA Health Sciences Trading Up 1.3%

USNA traded up $0.19 during trading hours on Tuesday, hitting $14.91. The company's stock had a trading volume of 290,210 shares, compared to its average volume of 148,543. The business's 50-day moving average price is $14.57 and its 200-day moving average price is $18.10. USANA Health Sciences has a 12 month low of $12.57 and a 12 month high of $23.59. The stock has a market cap of $275.46 million, a price-to-earnings ratio of -12.32, a P/E/G ratio of 1.60 and a beta of 0.68.

Analyst Ratings Changes

Several brokerages have issued reports on USNA. Wall Street Zen lowered USANA Health Sciences from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Zacks Research upgraded USANA Health Sciences from a "strong sell" rating to a "hold" rating in a research report on Monday, October 5th. Finally, Weiss Ratings reiterated a "sell (d)" rating on shares of USANA Health Sciences in a research report on Monday, September 21st. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Reduce".

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.

Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.

The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.